Yahoo! Finance Search - Finance Home - Yahoo! - Help

Thursday, March 26 2015 11:45pm ET - U.S. Markets Closed.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drugs - Generic News
Latest News
Thursday, Mar 26, 2015
·Agile Therapeutics reports 4Q loss
AP - Thu 4:58 pm ET
·Agile Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results
GlobeNewswire - Thu 4:15 pm ET
·Momentum bulls stick with Horizon
optionMONSTER - Thu 2:22 pm ET
·Diplomat Pharmacy (DPLO) Stock Surges Today After Pricing Public Offering
at - Thu 12:19 pm ET
·Synergy Pharma exploring sale - Bloomberg
Reuters - Thu 10:59 am ET
·Sagent Pharma founder Jeffrey Yordon to step down as CEO
Reuters - Thu 8:15 am ET
·Sagent Pharmaceuticals Announces Leadership Changes
GlobeNewswire - Thu 7:30 am ET
·pSivida Corp. Completes Targeted Enrollment of Phase III Trial of Medidurâ„¢ for Posterior Uveitis
Business Wire - Thu 7:00 am ET
·Zoetis bulls showing animal spirits
optionMONSTER - Thu 5:47 am ET
Wednesday, Mar 25, 2015
·Diplomat announces pricing of follow-on public offering of common stock
PR Newswire - Wed 9:00 pm ET
·SteadyMed Announces Closing of Initial Public Offering
GlobeNewswire - Wed 2:26 pm ET
·SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Akorn, Inc. and a Lead Plaintiff Deadline of May 4, 2015 -- AKRX
GlobeNewswire - Wed 11:59 am ET
Tuesday, Mar 24, 2015
·NephroGenex Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2014
Business Wire - Tue Mar 24
·Citi thinks pharmaceutical giant Teva is set for a 'material, potentially transformative, transaction'
Business Insider - Tue Mar 24
·Salix had a $13B offer on the table before accounting problems crashed share price
at - Tue Mar 24
·Talking Allergan at Tulane: a 'Horse Choker,' the 'Shamarendum' and More
at The Wall Street Journal Online - Tue Mar 24
·Portage's Biohaven enters into exclusive formulation agreement and global license with Catalent for lead product
PR Newswire - Tue Mar 24
·Lipocine Announces Results From Pre-NDA Meeting for LPCN 1021, an Oral Testosterone Product Candidate
GlobeNewswire - Tue Mar 24
·Relmada Therapeutics Receives Health Canada Clearance to Commence First Clinical Study for Novel Oral Formulations of Buprenorphine
PR Newswire - Tue Mar 24
·Galectin Therapeutics Presented Research With GR-MD-02 at the American Association for the Study of Liver Diseases Industry Colloquium
GlobeNewswire - Tue Mar 24
More Latest News...
Sponsor Results
Best Pharma Direct Mktg
The Internet Is The New Direct Mktg Targeted Marketing Every time.Call.
Tailored solutions in molecular biology and bioinformatics
Honolulu College Degree
Get Degree Honolulu College $5,730 Grant if Qualify. Act Now.
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds

Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?